NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies

Published:2012-02-07 Issue:4 Volume:11 Page:1006-1016
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Valsasina Barbara,Beria Italo,Alli Cristina,Alzani Rachele,Avanzi Nilla,Ballinari Dario,Cappella Paolo,Caruso Michele,Casolaro Alessia,Ciavolella Antonella,Cucchi Ulisse,De Ponti Anna,Felder Eduard,Fiorentini Francesco,Galvani Arturo,Gianellini Laura M.,Giorgini Maria L.,Isacchi Antonella,Lansen Jaqueline,Pesenti Enrico,Rizzi Simona,Rocchetti Maurizio,Sola Francesco,Moll Jürgen

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural insights into small-molecule KRAS inhibitors for targeting KRAS mutant cancers;European Journal of Medicinal Chemistry;2024-11

2. Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination;Frontiers in Oncology;2024-08-09

3. Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas;Cell Death & Disease;2024-07-22

4. Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-07-15

5. Therapeutic targeting of PLK1 in TERT promoter‐mutant hepatocellular carcinoma;Clinical and Translational Medicine;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP